Pasithea Therapeutics Corp (KTTA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2021 | 12-2020 | 09-2020 | |
| Cash Flows From Operating Activities | |||
| Net Income | -550 | -41 | 0 |
| Other Working Capital | 168 | 2 | 0 |
| Operating Cash Flow | $-382 | $-39 | $0 |
| Cash Flows From Investing Activities | |||
| Investing Cash Flow | $N/A | $0 | $0 |
| Cash Flows From Financing Activities | |||
| Common Stock Issued | 1,209 | N/A | N/A |
| Other Financing Activity | 0 | 282 | 0 |
| Financing Cash Flow | $1,209 | $282 | $0 |
| Beginning Cash Position | 244 | 0 | 0 |
| End Cash Position | 1,071 | 244 | 0 |
| Net Cash Flow | $827 | $244 | $0 |
| Free Cash Flow | |||
| Operating Cash Flow | -382 | -39 | 0 |
| Free Cash Flow | -382 | -39 | 0 |